West Pharmaceutical Services | WST - Interest Expense On Debt

Stock Price
230.95
Daily Change
-6.55 -2.76%
Monthly
-17.23%
Yearly
-30.24%
Q1 Forecast
224.00

West Pharmaceutical Services reported $200K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Align Technology USD 2M 660K Mar/2023
Avanos Medical USD 1.8M 200K Sep/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 155M 3M Sep/2025
Charles River Laboratories USD 25.4M 4.56M Sep/2025
Cooper Companies USD 24.4M 1000K Sep/2025
Dentsply International USD 23M 1000K Sep/2025
Haemonetics USD 7.21M 3.14M Sep/2025
ICU Medical USD 42.04M 18.97M Sep/2025
Insulet USD 7M 2.5M Sep/2025
Integra LifeSciences USD 22.72M 1.68M Sep/2025
IQVIA Holdings USD 189M 7M Sep/2025
J&J USD 18M 290M Sep/2025
Medtronic USD 181M 5M Sep/2025
Merit Medical Systems USD 6.78M 207K Jun/2025
Neogen USD 14.26M 1.26M Sep/2025
Quidel USD 5.68B 5.63B Sep/2025
Repligen USD 5.41M 60K Sep/2025
Solventum Corp USD 13.97B 13.87B Sep/2025
STAAR Surgical USD 1000 0 Dec/2024
Terumo JPY 18M 1.26B Sep/2025
West Pharmaceutical Services USD 200K 100K Sep/2025